- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Gefitinib
Total 407 results
-
AstraZenecaTerminatedCarcinoma, Non-Small-Cell LungTaiwan
-
Shanghai Pulmonary Hospital, Shanghai, ChinaUnknownNonsmall Cell Lung Cancer | EGFR Gene Mutation
-
IRCCS Azienda Ospedaliera Universitaria San Martino...Azienda Ospedaliera Universitaria Integrata Verona; Azienda Ospedaliera San... and other collaboratorsUnknownNon Small Cell Lung CancerItaly
-
National Cancer Institute (NCI)Completed
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC)United States, Australia, Belgium, Canada, Chile, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Peru, Portugal, Romania, Russian Federation, Singapore, Spain, Taiwan, Thailand, Ukraine, United Kingdom
-
Subha RamanBallou SkiesCompletedDuchenne Muscular DystrophyUnited States
-
M.D. Anderson Cancer CenterAstraZeneca; Aventis PharmaceuticalsWithdrawn
-
AstraZenecaCompletedHead and Neck CancerSpain
-
National Cancer Institute (NCI)CompletedSquamous Cell Carcinoma of the Skin | Recurrent Skin CancerUnited States
-
AstraZenecaCompleted
-
AstraZenecaCompletedNon Small Cell Lung CarcinomaAustralia
-
Novartis PharmaceuticalsCompletedNormal Hepatic Function | Impaired Hepatic FunctionUnited States
-
Novartis PharmaceuticalsCompletedNon-Small Cell Lung CancerUnited Kingdom, Taiwan, Belgium, Spain, Canada, Italy, Singapore, Japan, Russian Federation, Hong Kong, Thailand, Korea, Republic of, Norway, Australia, France, Sweden, United States, New Zealand
-
Eli Lilly and CompanyCompletedNon-small Cell Lung CancerChina, Korea, Republic of, Taiwan
-
Samsung Medical CenterUnknownNon-small Cell Lung CancerKorea, Republic of
-
Novartis PharmaceuticalsCompletedALK-activated TumorsFrance, Spain, Germany, Italy, Korea, Republic of, Canada, Australia, United Kingdom, Netherlands, United States
-
Novartis PharmaceuticalsCompleted
-
AstraZenecaCompletedNon-Small Cell Lung CancerItaly, Spain, France, Korea, Republic of, Hungary, Japan, China, Taiwan, Hong Kong, Germany, Russian Federation
-
National Institute for Medical Research, TanzaniaUniversiteit AntwerpenUnknownAnemia | Malaria,FalciparumTanzania
-
AstraZenecaCompletedNon-Small Cell Lung CancerPhilippines, China, Malaysia, Japan, Hong Kong, Taiwan, Thailand, Indonesia, Singapore
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerTaiwan, Korea, Republic of, Singapore, Thailand, Hong Kong
-
Novartis PharmaceuticalsTerminatedCeritinib (LDK378) for Patients Whose Tumors Have Aberrations in ALK or ROS1 (SIGNATURE) (SIGNATURE)Tumors With Aberrations in ALK or ROS1United States
-
Novartis PharmaceuticalsCompletedTumors Characterized by Genetic Alterations in Anaplastic Lymphoma Kinase (ALK)Japan
-
Melanoma Institute AustraliaNovartisRecruiting
-
Novartis PharmaceuticalsCompletedTumors Characterized by Genetic Abnormalities of ALKAustralia, Belgium, Germany, Netherlands, Spain, Italy, Singapore, Korea, Republic of, United Kingdom, United States, Canada
-
Novartis PharmaceuticalsCompletedNon-Small Cell Lung CancerCanada, Italy, United Kingdom, Spain, Netherlands, Singapore, Germany, Hong Kong, Japan, France, Korea, Republic of, United States
-
Eli Lilly and CompanyCompletedCarcinoma, Non Small Cell LungTaiwan, Japan, Korea, Republic of, China
-
H. Lee Moffitt Cancer Center and Research InstituteAstraZenecaCompletedGastric Cancer | Esophageal CancerUnited States, Puerto Rico
-
Novartis PharmaceuticalsCompletedNon-small Cell Lung Cancer | Anaplastic Lymphoma Kinase (ALK)Australia, Spain, Singapore, Italy, United States
-
Novartis PharmaceuticalsCompletedALK-positive Non-small Cell Lung CancerUnited States, France, Italy, United Kingdom, Taiwan, Turkey, Belgium, Germany, Canada, Singapore, Spain, Korea, Republic of, Netherlands, Russian Federation, Brazil, Hong Kong, Australia
-
AstraZenecaQuintiles, Inc.CompletedLocally Advanced or Metastatic Non-Small-Cell Lung Cancer (Stage IIIB-IV)United States
-
Gachon University Gil Medical CenterCompletedPrevious Treated Metastatic Non-small Cell Lung CancerKorea, Republic of
-
Novartis PharmaceuticalsNo longer availableNon-small Cell Lung Cancer (NSCLC)United States, Argentina, Korea, Republic of, Hong Kong, Thailand, Mexico, Jordan, Colombia, India, Philippines
-
Guangdong Association of Clinical TrialsPeking University First Hospital; Zhejiang Cancer Hospital; Peking University... and other collaboratorsUnknownNon-small Cell Lung CancerChina
-
Yonsei UniversityUnknownNon-small Cell Lung Cancer (NSCLC)Korea, Republic of
-
Novartis PharmaceuticalsCompletedAdenocarcinoma Lung Cancer; Squamous Cell Lung CarcinomaChina
-
Sun Yat-sen UniversityShenzhen People's Hospital; Sixth Affiliated Hospital, Sun Yat-sen University; Dongguan People's Hospital and other collaboratorsNot yet recruiting2-year Disease-Free SurvivalChina
-
AIO-Studien-gGmbHAstraZenecaTerminatedNSCLC | Non-squamous Non-small Cell Lung Cancer Stage II | Non-squamous Non-small Cell Lung Cancer Stage IIIA | Non-squamous Non-small Cell Lung Cancer Stage IIIB | Activating EGFR MutationGermany
-
Fudan UniversityUnknownNon-small Cell Lung Cancer | ToxicityChina
-
AstraZenecaCompleted
-
The University of Texas Health Science Center at...National Cancer Institute (NCI); Merck Sharp & Dohme LLC; University of TexasCompletedPancreatic CancerUnited States
-
University of Texas Southwestern Medical CenterNovartis PharmaceuticalsTerminatedALK-positive Non-small Cell Lung CancerUnited States
-
Novartis PharmaceuticalsCompletedNon-small Cell Lung CancerTaiwan, Spain, Italy, United States, Korea, Republic of, France
-
IRCCS Azienda Ospedaliera Universitaria San Martino...UnknownNon Small Cell Lung CancerItaly
-
Novartis PharmaceuticalsRecruitingAdvanced Solid Tumors Which Are cMET-dependentGermany, Korea, Republic of, Belgium, Italy, Singapore, United States, Denmark, Spain, France, Canada
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis PharmaceuticalsActive, not recruitingMelanoma | Unresectable Melanoma | Advanced MelanomaUnited States
-
Merck KGaA, Darmstadt, GermanyCompletedNon-small Cell Lung CancerSpain, Taiwan, Korea, Republic of, Singapore, China, Malaysia, Italy
-
National Cancer Center, KoreaAstraZenecaUnknownAdenocarcinoma | Non Small Cell Lung CancerKorea, Republic of
-
National Cancer Institute (NCI)TerminatedMucinous Adenocarcinoma of the Rectum | Signet Ring Adenocarcinoma of the Rectum | Mucinous Adenocarcinoma of the Colon | Signet Ring Adenocarcinoma of the Colon | Stage IV Colon Cancer | Stage IV Rectal Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Adenocarcinoma of the Rectum | Adenocarcinoma...United States